Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival
Advanced Science · 2026
DOI: 10.1002/advs.202520994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Ning Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangz…. Hauptthemen laut MEDLINE: Graft Survival, Hydrogels, Immunosuppressive Agents, Graft Rejection. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Pioneer" and "Leading Goose" R&D Program of Zhejiang, National Natural Science Foundation of China, Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Immunosuppressive therapy following organ transplantation is essential for ensuring long‐term graft survival but leaves patients vulnerable to complications such as infection, malignancy, and severe side effects. Immunosuppressants currently in use are typically hydrophobic with low oral bioavailability and must be taken indefinitely to maintain immune tolerance. Furthermore, these drugs lack tissue repair capacity, which limits their effectiveness in transplantation. To address this clinical gap, an immunomodulatory hydrogel (iGEL) was developed, integrating prodrug engineering with inflammation‐restricted pharmacokinetics. A binary pharmacology‐loaded iGEL spontaneously formed upon subcutaneous implantation using a dual‐syringe system. Acting as a tissue‐adhesive depot, iGEL released key antirejection and tissue‐regenerative agents, enabling localized immunomodulation in response to rejection‐induced inflammation. In mouse major histocompatibility complex–mismatched allo‐transplant models, iGEL suppressed T‐cell activity while promoting vascular reconstruction and regulating local cytokine profiles to remodel immune‐regenerative dynamics. For both immunocompetent and metabolically compromised hosts, iGEL effectively restored the functionality of skin allografts and markedly extended survival. The study introduces a locally syringeable and adaptive hydrogel depot that harnesses pathological cues to mediate complementary immune regulation and tissue repair, ensuring long‐term graft survival without systemic immunosuppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- NHC Key Laboratory of Combined Multi-Organ Transplantation, Key Laboratory of Organ Transplantation, Zhejiang Province. Institute of Organ Transplantation, National Clinical Research Center for Infectious Diseases, Zhej…
- Division of Lung Transplantation and Thoracic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Haiyang Xie
Förderung
- "Pioneer" and "Leading Goose" R&D Program of Zhejiang
- National Natural Science Foundation of China
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Wang, N., Sun, R., Fu, Y., Wu, Z., Tong, X., Tang, H., Zhao, W., Liang, Z., Zheng, J., Guan, Y., Zhou, K., Song, P., Zheng, S., Wang, H., & Xie, H. (2026). Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival. Advanced Science. https://doi.org/10.1002/advs.202520994
Vancouver
Wang N, Sun R, Fu Y, Wu Z, Tong X, Tang H, et al. Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival. Advanced Science. 2026. doi:10.1002/advs.202520994
BibTeX
@article{Wang2026,
author = {Wang, Ning and Sun, Ruiqi and Fu, Yang and Wu, Zhonghan and Tong, Xinyu and Tang, Hong and Zhao, Wentao and Liang, Zhi and Zheng, Jintao and Guan, Yanan and Zhou, Ke and Song, Penghong and Zheng, Shusen and Wang, Hangxiang and Xie, Haiyang},
title = {Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202520994}
}
EUVIMED